Primary Job Title Founder Primary Organization GID BIO, Inc.
Location Winston Salem, North Carolina, United States Regions East Coast, Southern US Gender Male
LinkedIn View on LinkedIn
Dr. Katz joined the faculty of the University of Florida College of Medicine in 2012 in the Division of Plastic Surgery where he is an Associate Professor, the Director of Plastic Surgery Research at the Laboratory of Bio-Innovation and Translational Therapeutics and Director of Clinical Trials for the Division of Plastic Surgery and the Department
of Surgery. After graduating from Duke University with a Bachelor’s degree in Neuroscience,
Dr. Katz obtained his M.D. from the University of Michigan Medical School, where he was president of the Alpha Omega Alpha National Honor Medical Society as well as a Hewlett-Packard Top Medical Graduate. His next eight years were spent at the University of Pittsburgh Medical Center for General and Plastic Surgery training.
During this time, he spent three years as a research fellow working on the isolation, culture, characterization and application of adipose-derived cells for therapeutic purposes, which culminated in several issued patents and several peer-reviewed publications that have contributed to the now active field of ‘applied adipose-derived therapeutics’. Upon joining the staff at University of Virginia in 2001, Dr. Katz initiated the Laboratory of Applied Developmental Plasticity, which he directed for 11 years.
In 2012, he joined the faculty of the University of Florida in the Division of Plastic Surgery. Dr. Katz was awarded The Academic Scholar of the American Association of Plastic Surgeons from 2002-2004, he is a member of The American Society of Plastic Surgeons (ASPS), The American Association of Plastic Surgeons (AAPS), and The Plastic Surgery Research Council, and serves on the Editorial Board of Annals of Plastic Surgery.
Dr. Katz is a co-founder, past president and board member of The International Federation for Adipose Therapeutics and Science (IFATS), a non-profit multidisciplinary society dedicated to facilitating the development of new technology derived from and directed toward adipose tissue.
In addition to his clinical practice and directing a research lab currently or previously funded by the NIH, Plastic Surgery research societies, and the Department of Defense, he remains entrepreneurially active having co-founded four companies over the last 12 years.
